| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| CSTLCastle Biosciences, Inc. | 1.19B | 40.75 | 65.73 | 51.09% | -3.56% | -2.62% | 3.07% | 0.06 |
| MYNZMainz Biomed B.V. | 10.78M | 1.19 | -0.05 | -0.17% | -24.92% | -6.63% | 0.54 | |
| BNRBurning Rock Biotech Limited | 301.02M | 33.32 | -0.99 | -4.02% | -22.48% | -22.06% | 0.09 | |
| MDXHMDxHealth S.A. | 190.56M | 3.71 | -3.20 | 28.29% | -40.43% | -345.31% | 4.05 | |
| PSNLPersonalis, Inc. | 853.41M | 9.61 | -7.01 | 15.15% | -106.92% | -43.1% | 0.22 | |
| EXASExact Sciences Corporation | 19.44B | 102.34 | -18.31 | 10.37% | -32.01% | -39.44% | 0.38% | 1.15 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 9.39M | 37.77M | 65.21M | 78.65M | 85.49M | 65.05M | 73.48M | 84.61M |
| Revenue Growth % | - | 3.02% | 0.73% | 0.21% | 0.09% | -0.24% | 0.13% | 0.15% |
| Cost of Goods Sold | 11.74M | 25.97M | 43.13M | 58.53M | 53.84M | 51.7M | 55.27M | 57.79M |
| COGS % of Revenue | 1.25% | 0.69% | 0.66% | 0.74% | 0.63% | 0.79% | 0.75% | 0.68% |
| Gross Profit | -2.34M | 11.8M | 22.08M | 20.11M | 31.66M | 13.35M | 18.21M | 26.82M |
| Gross Margin % | -0.25% | 0.31% | 0.34% | 0.26% | 0.37% | 0.21% | 0.25% | 0.32% |
| Gross Profit Growth % | - | 6.04% | 0.87% | -0.09% | 0.57% | -0.58% | 0.36% | 0.47% |
| Operating Expenses | 19.82M | 25.57M | 44.5M | 62.26M | 97.01M | 128.88M | 128.14M | 95.09M |
| OpEx % of Revenue | 2.11% | 0.68% | 0.68% | 0.79% | 1.13% | 1.98% | 1.74% | 1.12% |
| Selling, General & Admin | 9.9M | 11.27M | 22.08M | 33.69M | 47.7M | 63.97M | 49.73M | 46.19M |
| SG&A % of Revenue | 1.05% | 0.3% | 0.34% | 0.43% | 0.56% | 0.98% | 0.68% | 0.55% |
| Research & Development | 9.92M | 14.3M | 22.42M | 28.57M | 49.31M | 64.91M | 64.78M | 48.91M |
| R&D % of Revenue | 1.06% | 0.38% | 0.34% | 0.36% | 0.58% | 1% | 0.88% | 0.58% |
| Other Operating Expenses | 0 | -33K | 0 | 0 | 0 | 0 | 13.64M | 0 |
| Operating Income | -22.16M | -13.77M | -22.42M | -42.15M | -65.35M | -115.53M | -109.94M | -68.27M |
| Operating Margin % | -2.36% | -0.36% | -0.34% | -0.54% | -0.76% | -1.78% | -1.5% | -0.81% |
| Operating Income Growth % | - | 0.38% | -0.63% | -0.88% | -0.55% | -0.77% | 0.05% | 0.38% |
| EBITDA | -20.95M | -10.7M | -17.67M | -36.39M | -59.34M | -107.1M | -98.64M | -57.33M |
| EBITDA Margin % | -2.23% | -0.28% | -0.27% | -0.46% | -0.69% | -1.65% | -1.34% | -0.68% |
| EBITDA Growth % | - | 0.49% | -0.65% | -1.06% | -0.63% | -0.8% | 0.08% | 0.42% |
| D&A (Non-Cash Add-back) | 1.22M | 3.07M | 4.75M | 5.76M | 6.01M | 8.43M | 11.3M | 10.94M |
| EBIT | -22.29M | -17.98M | -23.94M | -41.22M | -65.03M | -113.07M | -108.1M | -81.24M |
| Net Interest Income | -1.2M | -1.6M | 487K | 947K | 183K | 2.19M | 5.79M | 5.49M |
| Interest Income | 100K | 293K | 1.62M | 949K | 367K | 2.4M | 5.9M | 5.51M |
| Interest Expense | 1.3M | 1.89M | 1.13M | 2K | 184K | 201K | 110K | 24K |
| Other Income/Expense | -1.43M | -6.11M | -2.66M | 923K | 141K | 2.26M | 1.72M | -13M |
| Pretax Income | -23.59M | -19.88M | -25.07M | -41.22M | -65.21M | -113.28M | -108.21M | -81.27M |
| Pretax Margin % | -2.51% | -0.53% | -0.38% | -0.52% | -0.76% | -1.74% | -1.47% | -0.96% |
| Income Tax | 5K | 7K | 9K | 57K | 14K | 40K | 83K | 18K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -23.6M | -19.89M | -25.08M | -41.28M | -65.23M | -113.31M | -108.3M | -81.28M |
| Net Margin % | -2.51% | -0.53% | -0.38% | -0.52% | -0.76% | -1.74% | -1.47% | -0.96% |
| Net Income Growth % | - | 0.16% | -0.26% | -0.65% | -0.58% | -0.74% | 0.04% | 0.25% |
| Net Income (Continuing) | -23.6M | -19.89M | -25.08M | -41.28M | -65.23M | -113.31M | -108.3M | -81.28M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.08 | -0.91 | -1.39 | -1.20 | -1.49 | -2.48 | -2.25 | -1.37 |
| EPS Growth % | - | 0.16% | -0.53% | 0.14% | -0.24% | -0.66% | 0.09% | 0.39% |
| EPS (Basic) | -1.08 | -0.91 | -1.39 | -1.20 | -1.49 | -2.48 | -2.25 | -1.37 |
| Diluted Shares Outstanding | 21.75M | 21.75M | 18.01M | 34.37M | 43.89M | 45.7M | 48.18M | 59.25M |
| Basic Shares Outstanding | 21.75M | 21.75M | 18.01M | 34.37M | 43.89M | 45.7M | 48.18M | 59.25M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 26.73M | 29.56M | 139.58M | 220.72M | 318.23M | 199.7M | 146.74M | 203.01M |
| Cash & Short-Term Investments | 22.62M | 19.74M | 128.29M | 203.29M | 287.06M | 167.66M | 114.18M | 185.01M |
| Cash Only | 22.62M | 19.74M | 55.05M | 68.53M | 105.58M | 89.13M | 56.98M | 91.42M |
| Short-Term Investments | 0 | 0 | 73.24M | 134.76M | 181.48M | 78.53M | 57.2M | 93.59M |
| Accounts Receivable | 1.94M | 4.46M | 3.3M | 6.35M | 18.47M | 16.64M | 17.73M | 8.14M |
| Days Sales Outstanding | 75.27 | 43.07 | 18.47 | 29.47 | 78.85 | 93.38 | 88.07 | 35.11 |
| Inventory | 822K | 2.13M | 1.42M | 2.67M | 4.08M | 6.38M | 5.66M | 3.98M |
| Days Inventory Outstanding | 25.56 | 29.99 | 12.05 | 16.68 | 27.67 | 45.07 | 37.38 | 25.11 |
| Other Current Assets | 542K | 1.3M | 3.18M | 2.96M | 1.53M | 9.02M | 9.17M | 5.89M |
| Total Non-Current Assets | 6.84M | 12.11M | 17.71M | 24.12M | 78.3M | 93M | 78.36M | 67.25M |
| Property, Plant & Equipment | 6.34M | 11.45M | 15.95M | 22.11M | 73.47M | 88.42M | 75.22M | 64.73M |
| Fixed Asset Turnover | 1.48x | 3.30x | 4.09x | 3.56x | 1.16x | 0.74x | 0.98x | 1.31x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 495K | 659K | 1.76M | 2.02M | 4.83M | 4.59M | 3.14M | 2.53M |
| Total Assets | 33.56M | 41.67M | 157.29M | 244.84M | 396.53M | 292.7M | 225.1M | 270.27M |
| Asset Turnover | 0.28x | 0.91x | 0.41x | 0.32x | 0.22x | 0.22x | 0.33x | 0.31x |
| Asset Growth % | - | 0.24% | 2.77% | 0.56% | 0.62% | -0.26% | -0.23% | 0.2% |
| Total Current Liabilities | 48.99M | 57.85M | 49.96M | 40.64M | 31.31M | 33.13M | 47.23M | 31.13M |
| Accounts Payable | 4.04M | 6.57M | 7.34M | 8.3M | 9.22M | 12.85M | 14.92M | 6.4M |
| Days Payables Outstanding | 125.49 | 92.27 | 62.1 | 51.76 | 62.52 | 90.75 | 98.53 | 40.4 |
| Short-Term Debt | 17.51M | 5M | 0 | 0 | 1.81M | 2.22M | 1.65M | 1.67M |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 718K | 43.18M | 4.39M | 8.45M | 11.19M | 9.55M | 19.62M | 10.86M |
| Current Ratio | 0.55x | 0.51x | 2.79x | 5.43x | 10.16x | 6.03x | 3.11x | 6.52x |
| Quick Ratio | 0.53x | 0.47x | 2.77x | 5.37x | 10.03x | 5.83x | 2.99x | 6.39x |
| Cash Conversion Cycle | -24.66 | -19.21 | -31.57 | -5.62 | 44 | 47.7 | 26.93 | 19.82 |
| Total Non-Current Liabilities | 77.18M | 90.21M | 639K | 9.26M | 54.91M | 41.43M | 48.42M | 36.19M |
| Long-Term Debt | 292K | 683K | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 639K | 8.54M | 52.8M | 41.04M | 38.32M | 34.88M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 76.89M | 89.53M | 0 | 720K | 2.12M | 389K | 10.1M | 1.3M |
| Total Liabilities | 126.17M | 148.06M | 50.6M | 49.9M | 86.23M | 74.56M | 95.66M | 67.31M |
| Total Debt | 17.51M | 5M | 2M | 10.99M | 58.33M | 48.65M | 47.73M | 44.25M |
| Net Debt | -5.11M | -14.75M | -53.05M | -57.54M | -47.25M | -40.48M | -9.26M | -47.17M |
| Debt / Equity | - | - | 0.02x | 0.06x | 0.19x | 0.22x | 0.37x | 0.22x |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | -17.01x | -7.27x | -19.79x | -21073.00x | -355.18x | -574.78x | -999.42x | -2844.46x |
| Total Equity | -92.6M | -106.39M | 106.69M | 194.94M | 310.3M | 218.14M | 129.44M | 202.96M |
| Equity Growth % | - | -0.15% | 2% | 0.83% | 0.59% | -0.3% | -0.41% | 0.57% |
| Book Value per Share | -4.26 | -4.89 | 5.92 | 5.67 | 7.07 | 4.77 | 2.69 | 3.43 |
| Total Shareholders' Equity | -92.6M | -106.39M | 106.69M | 194.94M | 310.3M | 218.14M | 129.44M | 202.96M |
| Common Stock | 1K | 1K | 3K | 4K | 4K | 5K | 5K | 9K |
| Retained Earnings | -95.62M | -115.5M | -140.59M | -181.87M | -247.09M | -360.41M | -468.71M | -549.99M |
| Treasury Stock | -3.02M | -9.13M | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -10K | -15K | -6K | 22K | -166K | -912K | -222K | -23K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 290K | 5.57M | -18.07M | -42.65M | -70.83M | -70.23M | -56.26M | -45.15M |
| Operating CF Margin % | 0.03% | 0.15% | -0.28% | -0.54% | -0.83% | -1.08% | -0.77% | -0.53% |
| Operating CF Growth % | - | 18.21% | -4.24% | -1.36% | -0.66% | 0.01% | 0.2% | 0.2% |
| Net Income | -23.6M | -19.89M | -25.08M | -41.28M | -65.23M | -113.31M | -108.3M | -81.28M |
| Depreciation & Amortization | 1.22M | 3.07M | 4.75M | 5.76M | 6.01M | 8.43M | 11.3M | 10.94M |
| Stock-Based Compensation | 753K | 1.32M | 4.86M | 8.24M | 14.38M | 19.43M | 14.05M | 10.69M |
| Deferred Taxes | 226K | 4.47M | 3.11M | 391K | 2.03M | 0 | 0 | 0 |
| Other Non-Cash Items | 934K | 1.18M | 1.56M | 1.47M | 3.12M | 4.61M | 13.21M | 17.1M |
| Working Capital Changes | 20.76M | 15.42M | -7.26M | -17.23M | -31.14M | 10.61M | 13.48M | -2.59M |
| Change in Receivables | -1.2M | -2.52M | 1.07M | -3.05M | -12.12M | 1.82M | -1.09M | 9.59M |
| Change in Inventory | -539K | -2.07M | -1.17M | -1.08M | 29K | -2.98M | -1.93M | 4.42M |
| Change in Payables | 2.63M | 2.16M | 1.4M | 751K | -1.46M | 3.09M | 5.18M | -8.92M |
| Cash from Investing | -5.16M | -7.85M | -81.58M | -65.14M | -60.07M | 52.54M | 13.1M | -35.07M |
| Capital Expenditures | -5.16M | -7.85M | -8.38M | -3.25M | -11.08M | -49.9M | -10.91M | -1.6M |
| CapEx % of Revenue | 0.55% | 0.21% | 0.13% | 0.04% | 0.13% | 0.77% | 0.15% | 0.02% |
| Acquisitions | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -73.2M | -65.14M | -48.99M | 0 | 24.01M | 242K |
| Cash from Financing | 16.4M | -591K | 134.95M | 121.27M | 169.7M | 1.37M | 11.03M | 114.67M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - |
| Other Financing | 2K | 54K | -4.08M | 3.77M | 4.13M | 2.46M | 7.34M | 17.98M |
| Net Change in Cash | - | - | - | - | - | - | - | - |
| Free Cash Flow | -4.87M | -2.28M | -26.45M | -45.9M | -81.91M | -120.13M | -67.17M | -46.75M |
| FCF Margin % | -0.52% | -0.06% | -0.41% | -0.58% | -0.96% | -1.85% | -0.91% | -0.55% |
| FCF Growth % | - | 0.53% | -10.6% | -0.74% | -0.78% | -0.47% | 0.44% | 0.3% |
| FCF per Share | -0.22 | -0.10 | -1.47 | -1.34 | -1.87 | -2.63 | -1.39 | -0.79 |
| FCF Conversion (FCF/Net Income) | -0.01x | -0.28x | 0.72x | 1.03x | 1.09x | 0.62x | 0.52x | 0.56x |
| Interest Paid | 321K | 698K | 1.26M | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | -5K | -7K | 6K | 35K | 39K | 47K | 64K | 38K |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -16611.92% | -27.37% | -25.82% | -42.89% | -62.31% | -48.91% |
| Return on Invested Capital (ROIC) | - | - | -31.34% | -33.09% | -24.48% | -39.32% | -55.37% | -37.11% |
| Gross Margin | -24.94% | 31.25% | 33.86% | 25.57% | 37.03% | 20.52% | 24.78% | 31.7% |
| Net Margin | -251.23% | -52.64% | -38.47% | -52.49% | -76.29% | -174.2% | -147.38% | -96.06% |
| Debt / Equity | - | - | 0.02x | 0.06x | 0.19x | 0.22x | 0.37x | 0.22x |
| Interest Coverage | -17.01x | -7.27x | -19.79x | -21073.00x | -355.18x | -574.78x | -999.42x | -2844.46x |
| FCF Conversion | -0.01x | -0.28x | 0.72x | 1.03x | 1.09x | 0.62x | 0.52x | 0.56x |
| Revenue Growth | - | 302.15% | 72.62% | 20.61% | 8.7% | -23.92% | 12.97% | 15.15% |
Personalis, Inc. (PSNL) reported $69.1M in revenue for fiscal year 2024. This represents a 636% increase from $9.4M in 2017.
Personalis, Inc. (PSNL) grew revenue by 15.2% over the past year. This is strong growth.
Personalis, Inc. (PSNL) reported a net loss of $73.9M for fiscal year 2024.
Personalis, Inc. (PSNL) has a return on equity (ROE) of -48.9%. Negative ROE indicates the company is unprofitable.
Personalis, Inc. (PSNL) had negative free cash flow of $66.2M in fiscal year 2024, likely due to heavy capital investments.